Please login to the form below
PSI appoints new country manager for Germany
Sabine Debuschewitz will be based at the CRO's Munich office
PSI has appointed Sabine Debuschewitz as its new country manager for Germany.
She brings to the Swiss clinical research organisation (CRO) more than 15 years' clinical research experience in pharma, biotech and CROs.
Debuschewitz will be based at the company's Munich office, which also houses PSI's global heads of medical affairs, clinical operations, and training and resourcing.
COVID-19 Updates and Daily News
Featured jobs
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
-
Senior Account Manager
-
Salary TBC
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Planner
-
Salary TBC
-
Publications Director
-
Competitive Salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Eli Lilly demonstrates Verzenio win in high-risk breast cancer subset at ASCO
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- Merck & Co spinoff Organon launches with the aim of 'improving health outcomes for women'
- FDA advisory committee overwhelmingly votes no on Biogen's aducanumab
- BeiGene’s reveals positive data for Brukinsa in head-to-head Imbruvica trial
- BMS, Acceleron’s Reblozyl shows new improvements for beta thalassemia patients
- Biogen reports new data backing long-term benefit of Spinraza
- G7 expected to donate one billion COVID-19 vaccine doses
- Anna Korving joins Resonant Group as non-executive director
- Resonant Group appoints Stephen Marchant as chief development officer
- Novo Nordisk says Victoza outperforms SGLT2 inhibitors
- Nicky Hutchens appointed as deputy managing director at Four Health
- Positive results for AZ, Merck & Co’s Lynparza in early breast cancer presented at ASCO
- Product launches: making the most of your one shot
- Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases
- Merck & Co spinoff Organon launches with the aim of 'improving health outcomes for women'
PMHub
certain health
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...
Latest intelligence
- Article:
- The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
- The pursuit of patient diversity in clinical trials
- When all-inclusive isn’t an option, it’s an obligation...
- Overcoming the digital patient recruitment challenges of connecting with patients
- How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...
